Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia A and inhibitors

Seminars in Hematology

Volumn 43, Issue SUPPL. 1, 2006, Pages

  D'Oiron, Roseline ^a,d   Volot, F ^b   Reynaud, J ^c   Peerlinck, K ^d   Goudemand, J ^e   Guerois C ^f   Rothschild, C ^g   Chambost, H ^h   Borel Derlon, A ⁱ   Roussel Robert, V ^j   Marques Verdier A ^k   Lienhart, A ^l   Berthier, A M ^m   Moreau, P ⁿ   Lambert, T ^a  

^a BICÊTRE HOSPITAL   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF TOURS   (France)

^g University Hospital   (France)

^h La Conception   (France)

ⁱ CAEN UNIVERSITY HOSPITAL   (France)

^j NONE   (France)

^k UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^l University Hospital   (France)

^m RENNES UNIVERSITY HOSPITAL   (France)

ⁿ University Hospital   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADULT; ANAMNESIS; BLEEDING; BLEEDING DISORDER; BLOOD CLOT; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; GENE MUTATION; HEMOPHILIA A; HUMAN; HYPONATREMIA; IMMUNOLOGICAL TOLERANCE; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TONGUE DISEASE; TREATMENT OUTCOME;

BLOOD COAGULATION FACTOR INHIBITORS; CHILD; CHILD, PRESCHOOL; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMORRHAGE; HUMANS; INFANT; MALE; TREATMENT OUTCOME;

EID: 31444447423     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.11.002     Document Type: Conference Paper

References (45)

1. P. Beck, J.C. Giddings, A.L. Bloom Inhibitor of factor VIII in mild hemophilia Br J Haematol 17 1969 283 288
2. C.R.M. Hay, C.A. Ludlam, B.T. Colvin, F.G.H. Hill, F.E. Preston, N. Wasseem Factor VIII inhibitors in mild and moderate-severity haemophilia A Thromb Haemost 79 1998 762 766
3. H. Ören, I. Yaprak, G. Irken Factor VIII inhibitors in patients with hemophilia A Acta Haematol 102 1999 42 46
4. B.T. Colvin, C.R.M. Hay, F.G. Hill, F.E. Preston The incidence of factor VIII inhibitors in the United Kingdom, 1990-93 Br J Haematol 89 1995 908 910
5. S. Ehrenforth, W. Kreuz, I. Scharrer, R. Linde, M. Funk, T. Gungor Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs Lancet 339 1992 594 598
6. J. Oldenburg, O. El-Maarri, R. Schwaab Inhibitor development in correlation to factor VIII genotypes Haemophilia 8 2002 23 29
7. J.M. Lusher, S. Arkin, C.F. Abildgaard, R.S. Schwartz Kogenate Previously Untreated Patient Study Group Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors N Engl J Med 328 1993 453 459
8. A. Sharathkumar, D. Lillicrap, V.S. Blanchette, M. Kern, J. Leggo, A.M. Stain Intensive exposure to factor VIII is a risk for inhibitor development in mild hemophilia A J Thromb Haemost 1 2003 1228 1236
9. F. Bauduer, L. Ducout, P. Bendriss, B. Falaises, J.M. Lavergne Mild haemophilia A discovered in a previously multi-operated 73-year-old man Characterization of a new mutation Haemophilia 7 2001 419 421
10. E.G. Bovill, S.L. Burns, E.A. Golden Factor VIII antibody in a patient with mild haemophilia Br J Haematol 61 1985 323 328
11. P. Capel, M. Toppet, E. van Remoortel, P. Fondu Factor VIII inhibitor in mild haemophilia Br J Haematol 62 1986 786 787
12. E.B. Crowell A factor VIII inhibitor in a mild hemophiliac Am J Med Sci 260 1970 261 263
13. 593→Cys is related to antibody formation in a patient with mild hemophilia A Blood 89 1997 4371 4377
14. P.J. Kesteven, L.J. Holland, A.S. Lawrie, G.F. Savidge Inhibitor to factor VIII in mild haemophilia Thromb Haemost 52 1984 50 52
15. K.E. Knobe, B.O. Villoutreix, L.I. Tengborn, P. Petrini, R.C. Ljung Factor VIII inhibitors in two families with mild haemophilia A Structural analysis of the mutations Haemostasis 30 2000 268 279
16. ®) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII Haemophilia 10 2004 250 253
17. K. Lechner, E. Ludwig, H. Niessner, E. Thaler Factor VIII inhibitor in a patient with mild hemophilia A Hemostasis 1 1972 261 270
18. M.L. Liu, S. Nakaya, A.R. Thompson Non-inversion factor VIII mutations in 80 hemophilia A families including 24 with alloimmune responses Thromb Haemost 87 2002 273 276
19. G. Lowe, C.D. Forbes Inhibitor to factor VIII in mild haemophilia Thromb Haemost 53 1985 159
20. K. Peerlinck, J. Arnout, M. Jacquemin, J.G. Gilles, R. Lavend'homme, K. Kreson A patient with mild hemophilia and a high titer antifactor VIII antibody against exogenous factor VIII only Clinical features, surgical management and partial characterization of the inhibitor Blood 90 suppl 1 1997 36a
21. K. Peerlinck, M.G. Jacquemin, J. Arnout, M.F. Hoylaerts, J.G.G. Gilles, R. Lavend'homme Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A Blood 93 1999 2267 2273
22. J.J. Puetz, J.D. Bouhasin High-titre factor VIII inhibitor in two children with mild haemophilia A Haemophilia 7 2001 215 219
23. D. Robbins, R. Kulkarni, R. Gera, A.B. Scott-Emuakpor, K. Bosma, J.A. Penner Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy Am J Hematol 68 2001 184 188
24. V. Roussel-Robert, M.F. Torchet, F. Legrand, C. Rothschild, N. Stieltjes Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients J Thromb Haemost 1 2003 2450 2541
25. E. Santagostino, A. Gringeri, L. Tagliavacca, P.M. Mannucci Inhibitors to factor VIII in a family with mild hemophilia molecular characterization and response to factor VIII and desmopressin Thromb Haemost 74 1995 619 621
26. T. Suzuki, M. Arai, S. Miyasaka, J. Watanabe, D. Sugimura, K. Amano Factor VIII inhibitor developed in a 60-year-old patient with mild hemophilia A after surgery for colon cancer Int J Hematol 62 1995 127 132
27. 593 to Cys mutation Blood 90 1997 1902 1910
28. T.T. Yee, K.J. Pasi, P.A. Lilley, C.A. Lee Factor VIII inhibitors in haemophiliacs A single-centre experience over 34 years, 1964-97 Br J Haematol 104 1999 909 914
29. B. White, M. Cotter, M. Byrne, E. O'Shea, O.P. Smith High responding factor VIII inhibitors in mild haemophilia - Is there a link with recent changes in clinical practice? Haemophilia 6 2000 113 115
30. 593→ Cys substitution Thromb Haemost 81 1999 723 726
31. White GC II, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J, on behalf of the Factor VIII and Factor IX Subcommittee: Classification of inhibitors. Scientific Subcommittees on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, Minutes and Annual report 2000, http://www.med.unc. edu/isth/SSC/communications/factor8and9/defhem.pdf
32. Gill J: Proposal to refine the low response inhibitor definition. Scientific Subcommittees on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, Minutes and Annual report 2004, http://www.med.unc.edu/isth
33. J. Oldenburg, J. Schroder, H. Hermann Brackmann, C. Muller-Reible, R. Schwaab, E. Tuddenham Environmental and genetic factors influencing inhibitor development Semin Hematol 41 suppl 1 2004 82 88
34. G. Kemball-Cook, E.G. Tuddenham, A.I. Wacey The factor VIII structure and mutation resource site HAMSTeRS version 4 Nucleic Acids Res 26 1998 216 219
35. M. Jacquemin, A. Benhida, K. Peerlinck, B. Desqueper, L. Vander Elst, R. Lavend'homme A human antibody directed to the factor VIII domain inhibits factor VIII cofactor activity and binding to von Willebrand factor Blood 95 2000 156 163
36. M. Jacquemin, R. Lavend'homme, A. Benhida, B. Vanzieleghem, R. d'Oiron, J.M. Lavergne A novel cause of mild/moderate hemophilia A mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor Blood 96 2000 958 965
37. 593→Cys mutation using phage display Br J Haematol 119 2002 393 396
38. 593 to Cys mutation Haemophilia 10 2004 509 514
39. C.R. Hay, W. Ollier, L. Pepper, A. Cumming, S. Keeney, A.C. Goodeve HLA class II profile A weak determinant of factor VIII inhibitor development in severe hemophilia A Thromb Haemost 77 1997 234 237
40. J. Oldenburg, J.K. Picard, R. Schwaab, H.H. Brackmann, E.G. Tuddenham, E. Simpson HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII Thromb Haemost 77 1997 238 242
41. J. Astermark, E. Berntorp, G.C. White, B.L. Kroner The MIBS Study Group The Malmö International Brother Study (MIBS) Further support for genetic predisposition to inhibitor development Haemophilia 7 2001 267 272
42. 618→Ser mutation responsive to immune tolerance induction and cyclophosphamide Br J Haematol 117 2002 136 140
43. A. Wiestner, H.J. Cho, A.S. Asch, M.A. Michells, J.A. Zeller, E.I.B. Peerschke Rituximab in the treatment of acquired factor VIII inhibitors Blood 100 2002 3426 3428
44. M. Johannessen, R.B. Andreasen, O. Nordfang Decline of factor VIII and factor IX inhibitors during long-term treatment with NovoSeven Blood Coagul Fibrinolysis 11 2000 239 242
45. G. Karayalcin, B. Goldberg, I. Cherrick, C. Kurer, F. Bierman, P. Lanzkowsky Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor Am J Pediatr Hematol Oncol 15 1993 416 419